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A B S T R A C T
Tissue fibrosis, an accumulation of extracellular matrix proteins such as collagen, accompanies cardiac ageing in
humans and this is linked to an increased risk of cardiac failure. The mechanisms driving age-related tissue
fibrosis and cardiac dysfunction are unclear, yet clinically important. Drosophila is amenable to the study of
cardiac ageing as well as collagen deposition; however it is unclear whether collagen accumulates in the ageing
Drosophila heart.
This work examined collagen deposition and cardiac function in ageing Drosophila, in the context of reduced
expression of collagen-interacting protein SPARC (Secreted Protein Acidic and Rich in Cysteine) an evolutio-
narily conserved protein linked with fibrosis. Heart function was measured using high frame rate videomicro-
scopy. Collagen deposition was monitored using a fluorescently-tagged collagen IV reporter (encoded by the
Viking gene) and staining of the cardiac collagen, Pericardin.
The Drosophila heart accumulated collagen IV and Pericardin as flies aged. Associated with this was a decline
in cardiac function. SPARC heterozygous flies lived longer than controls and showed little to no age-related
cardiac dysfunction. As flies of both genotypes aged, cardiac levels of collagen IV (Viking) and Pericardin in-
creased similarly. Over-expression of SPARC caused cardiomyopathy and increased Pericardin deposition.
The findings demonstrate that, like humans, the Drosophila heart develops a fibrosis-like phenotype as it ages.
Although having no gross impact on collagen accumulation, reduced SPARC expression extended Drosophila
lifespan and cardiac health span. It is proposed that cardiac fibrosis in humans may develop due to the activation
of conserved mechanisms and that SPARC may mediate cardiac ageing by mechanisms more subtle than gross
accumulation of collagen.
1. Introduction
Collagens are crucial for the development of form and function in
multicellular animals. In mammals, increased collagen deposition oc-
curs in response to injury as part of the tissue repair process (Wynn,
2008). Collagen accumulation in humans, typically referred to as tissue
fibrosis, is a clinically important feature of chronic disease states as well
as ageing. In both humans and mammalian models, tissue fibrosis is
linked to organ dysfunction and an increased risk of mortality. Under-
standing the molecular genetics of collagen deposition and fibrosis is
therefore an important step towards developing anti-fibrotic therapies.
Fibrosis-related proteins and the signalling pathways leading to fibrosis
show a high degree of genetic and functional conservation in the animal
kingdom (Volk et al., 2014; Hartley et al., 2016; Sessions et al., 2016).
The fruit or vinegar fly, Drosophila melanogaster expresses several col-
lagen genes, as well as matricellular proteins required for the assembly
of extracellular matrices (Yasothornsrikul et al., 1997; Martinek et al.,
2008). Collagens and associated matricellular proteins are important
mediators of cardiac development in Drosophila (Hartley et al., 2016;
Chartier et al., 2002; Drechsler et al., 2013). Despite Drosophila being
highly amenable to studies of age-related cardiac decline (Wessells
et al., 2004; Cannon et al., 2017; Klassen et al., 2017; Lee et al., 2010;
Nishimura et al., 2014; Monnier et al., 2012), there are currently no
studies examining collagen deposition in the ageing heart.
SPARC (Secreted Protein Acidic and Rich in Cysteine) is a well-
characterised collagen binding matricellular protein involved in tissue
fibrosis (Weaver et al., 2008; Bradshaw, 2012). SPARC is evolutionarily
and functionally conserved and known to mediate collagen deposition
in Drosophila embryos (Martinek et al., 2008). SPARC expression is
increased in a number of clinically important settings and accumulates
(along with other extracellular matrix (ECM) proteins) in the ageing
mammalian heart (Bradshaw et al., 2010; de Castro Bras et al., 2014),
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suggesting it may play a role in cardiac dysfunction in human ageing.
Recent findings indicate that reduced SPARC expression can correct
cardiomyopathy in Drosophila (Hartley et al., 2016). In addition, re-
duced expression of the ECM proteins Laminin, Viking and Pericardin in
the Drosophila heart can impede age-related cardiac dysfunction
(Sessions et al., 2016). Despite this knowledge, there is no data on
whether ECM proteins accumulate within the ageing Drosophila heart.
Embryonic and larval development of Drosophila is dependent on
the expression of type-IV collagen α2 and α1 chains encoded by Viking
and Cg25C, as well as Multiplexin (an ortholog of human COL18A1) and
the heart specific type-IV-like collagen, Pericardin; the latter two pro-
teins being integral to cardiac development (Chartier et al., 2002;
Harpaz et al., 2013). Although Pericardin was initially described as a
matrix forming type-IV-like collagen, it also adopts prominent fibre-like
structures and acts as a ‘tendenous’ bridge between the heart and alary
muscles. How these collagenous fibres are formed and maintained re-
mains largely uncharacterised.
In humans and mammalian models, fibrosis is regarded as an ac-
cumulation of extracellular matrix in a given tissue. Most attention has
focused on fibril forming collagens, however fibrosis is complex and
outcomes in terms of organ function are affected not only by the gross
accumulation of collagen subtypes and other ECM proteins but also by
the ratios of different collagens and ECM proteins (Karsdal et al., 2017).
Experimental evidence indicates that Drosophila may be a tractable
model with which to study the mechanisms leading to tissue fibrosis in
humans. For example, an accumulation of collagen in and around
Drosophila adipocytes alters innate immunity (Zang et al., 2015)
whereas diet-dependent changes to Drosophila heart function are asso-
ciated with cardiac fibrosis (Na et al., 2013). These findings make
Drosophila a valuable tool with which to understand and identify me-
chanisms regulating collagen deposition and its impact on organ func-
tion. Given that collagen turnover (i.e. the expression, deposition and
degradation of collagen) as well as the ageing process are evolutionarily
conserved, it was predicted that collagen may accumulate as part of the
ageing process in the Drosophila heart model and that SPARC may
mediate this process.
In this report we describe the accumulation of collagen in the ageing
Drosophila heart and show that this accompanies the well-described
age-dependent functional decline of the fly's heart. It is also shown that
SPARC heterozygous flies have a longer lifespan as well as extended
cardiac health span. Despite this, the accumulation of collagen around
the heart does not seem to be affected by reduced SPARC expression;
whereas, SPARC over-expression led to cardiomyopathy and Pericardin
accumulation. The findings support the idea that age-related fibrosis in
mammals is an evolutionarily conserved process which can be studied
in simpler, genetically tractable models.
2. Materials and methods
2.1. Stock chemicals and fly husbandry
Picrosirius red and all stock chemicals were from Sigma (Poole,
Dorset, UK). The Canton Special, w1118, yw, SPARCMI00329 (with a MiMIC
insertion in the 5-prime region of the SPARC locus; described in
(Venken et al., 2011)) and Viking-GFP strains were obtained from the
Bloomington Drosophila Stock Centre. The Dorothy-Gal4 line was de-
scribed previously (Kimbrell et al., 2002) and is used to drive the ex-
pression of genes downstream of a UAS (upstream activation sequence)
element. The UAS-SPARC line was described in (Martinek et al., 2008).
Flies were reared and maintained on a standard cornmeal-yeast-agar
diet under 12 h:12 h light:dark cycles at 25 °C. SPARCMI00329 were
backcrossed to a yw background for> 6 generations and then out-
crossed once to the w1118 line to generate heterozygous flies for phe-
notyping and lifespan studies.
2.2. Lifespan studies
Ten male or female flies within 1 day of eclosion were collected and
transferred to fresh vials with standard diet. Five to ten vials per trial
were prepared. At least two trials were conducted for each genotype.
Vials were maintained on their side and flies tipped to fresh food twice
per week for the duration of the lifespan studies. All vials were main-
tained under 12 h:12 h light:dark cycles at 25 °C. Lifespan data is pre-
sented as Kaplan-Meier plots as well as the mean of the median (the
point at which 50% of the population had died) and maximum lifespan
(± SEM).
2.3. Histochemistry, imaging and qPCR
Adult flies were anaesthetised by brief exposure to CO2, hearts were
exposed by dissection and fixed using 1% formaldehyde for 15 min.
Picrosirius red dye was then added for 5 min at ambient temperature
and rinsed from dissected hearts using acidified water (1% acetic acid
in water). Picrosirius red comprises sulphonic acid and stains the basic
amine residues of most proteins but preferentially stains collagens be-
cause of their abundance and the large number of glycine residues.
Colour phase images were captured on a Leica DMLB fitted with a Leica
DC300 colour camera, images were taken using μManager software
(Edelstein et al., 2010). Pericardin was imaged after staining dissected
hearts with the mouse-anti Pericardin monoclonal antibody clone EC11
(Zaffran et al., 1995) (Developmental Studies Hybridoma Bank, Uni-
versity of Iowa) followed by a fluorescently-tagged secondary antibody.
Fluorescence images were taken using a Zeiss LSM 710 confocal mi-
croscope and images quantified using ImageJ by drawing a line across a
region of interest and recoding the maximum fluorescence signal.
2.4. Analysis of cardiac Pericardin
Hearts stained with anti-Pericardin antibodies were imaged by
confocal microscopy and z-projections of stacks analysed in ImageJ.
The same number of z-projected stacks was sued for each genotype and
age. All images were of the distal region of the heart comprising ap-
proximately 2/3 of the total heart, where the majority of anti-
Pericardin staining is found. Images were thresholded and the percen-
tage of Pericardin positive signal quantified as a percentage of the total
image. For measurement of Pericardin fibre thickness, single confocal
image stacks were used and at least six fibre measurements were taken
from four different flies. Data are presented as the mean fibre thickness
(± SEM).
2.5. Heart function analysis
Adult flies were anaesthetised by brief exposure to Triethylamine
vapour (20 μL of a 50% solution made in 50% ethanol/water, placed
into the underside of a fly vial's cotton cap). Flies were dissected as
described previously (Catterson et al., 2013) and imaged using a Zeiss
Axiolab microscope fitted with a water immersion 10× objective,
linked to a Myocam S (Ionoptix Ltd., Ireland) high speed video camera.
The beating heart was imaged for 10–20 s at 120 frames per second
(fps) and heart function analysed using SOHA (Fink et al., 2009). For
heart analysis involving SPARC over-expression, video capture was
performed with a Ximea XDi camera and a frame rate of 25 fps.
2.6. Western Blotting
For each lane 10 female hearts were harvested and directly lysed in
10 μL Ripa buffer (Sigma, Poole, UK). Polypeptides were separated on a
4–20% SDS-page gel and transferred to a PVDF membrane. The mem-
brane was then probed with anti-pericardin (DSHB, EC11) and anti-
actin (DSHB JLA20) antibodies followed by secondary antibodies con-
jugated to alkaline phosphatase. Secondary antibodies were detected
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using NBT (nitro-blue tetrazolium chloride) with BCIP (5-bromo-4-
chloro-3′-indolyphosphate p-toluidine salt).
2.7. Statistics
When two means were compared, an unpaired two-tailed student's t-
Test was applied to establish the P-value. When mean data for genotype
and age were compared in an experiment, two-way ANOVA was used.
Graphs show mean± SEM.
3. Results
3.1. Overall collagen and collagen-IV deposition increases in older flies
To assess collagen deposition in the heart two approaches were
initially used. Firstly picrosirius red, a histochemical dye used widely to
quantify collagen in mammalian tissue section was used to stain the
heart of one-week and six-week-old wild type (Canton S) Drosophila.
The adult Drosophila heart exhibited extensive pink-red staining that
became more intense in older flies (inset Fig. 1A and B). Quantification
of the signal was not possible due to older flies developing a red-brown
pigmentation in their cuticle which affected colour-based image ana-
lysis. The second approach used flies expressing a fluorescently tagged
Fig. 1. The Viking-GFP signal accumulates at all regions of the ageing
heart.
(A and B) The heart of adult flies expressing a Viking-GFP fusion
protein shows an increase of signal over six weeks. This insets show
the signal from the histological stain picrosirius red of similarly aged
Canton S wild type flies. The Viking-GFP signal is increased at the
valve (arrows), conical chamber (arrowheads) and distal heart (as-
terisk); scale bar = 150 μm. Confocal images and quantified data of
the Viking-GFP signal at the distal heart (C, F and I), valves (D, G and
J) and longitudinal muscles of the conical chamber (E, H and K) of one
and six week old flies. V = valves. Quantified data was obtained from
four to six individual flies at each age. Mean fluorescence is expressed
in arbitrary units± SEM. P values were determined by t-Test.
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collagen-IV protein encoded by the viking gene (Morin et al., 2001).
This reporter system has been used to visualise collagen-IV during
embryogenesis and egg morphogenesis and reliably reports Viking
protein distribution in basement membranes (Pastor-Pareja and Xu,
2011; Haigo and Bilder, 2011). In accordance with the picrosirius red
results, Viking-GFP fluorescence was abundant along the heart of adult
flies and particularly intense at the 1st, 2nd and 3rd valve pairs (arrow
denotes the 2nd valve pair in Fig. 1A), the distal heart (asterisks Fig. 1A
and B) and the longitudinal muscles, especially those overlying the
conical chamber (arrowheads, Fig. 1A and B). As for the picrosirius red
result, the Viking-GFP signal at the distal heart, valve and longitudinal
muscles (Fig. 1C–E) was markedly increased in older flies (Figs. F–H).
Unlike the picrosirius red signal, the Viking-GFP fluorescence signal
was amenable to quantification and recorded as significantly increasing
at the distal heart, valves and longitudinal muscles of one and six-week-
old flies (Fig. 1I–K; P < 0.01). Additionally, valve cells exhibited age-
dependent remodelling (Supplemental Fig. S1). This change to valve
morphology in Drosophila does not appear to have been documented
before but may reflect the senescence-related changes known to occur
to human aortic valve leaflets (Collins et al., 2014).
3.2. Cardiac Pericardin accumulation
In addition to Collagen-IV quantification, the level of Pericardin was
quantified in one and six-week old flies (Fig. 2). Pericardin is a type-IV-
like collagen associated exclusively with the insect dorsal vessel
(Chartier et al., 2002). Hearts of w1118 flies stained with antisera to
Pericardin exhibited a complex network of overlapping Pericardin fi-
bres, which were especially concentrated at the distal heart region
(Fig. 2A) and between adjacent nephrocytes and the heart tube (not
shown). The immunofluorescence signal for Pericardin in six week old
flies was increased relative to younger, one week old flies (Fig. 2B;
P < 0.01). Western blot analysis of total cell lysates from isolated
hearts confirmed an increased level of cardiac Pericardin on older flies
(Fig. 2C and D; P < 0.05). In addition, Pericardin fibre thickness was
analysed in single confocal sections and also found to be greater in
older flies (Fig. 2E–H; P < 0.05).
3.3. Reduced SPARC expression is associated with extended lifespan
It is well established that, like the mammalian heart, there is an age-
dependent decline in cardiac function in Drosophila (Wessells et al.,
2004). In addition, there is an association between increased Pericardin
deposition and abnormal cardiac function in a diet-induced Drosophila
cardiomyopathy model (Na et al., 2013). Recent evidence from the
Drosophila heart model indicates that SPARC mediates the development
of a cardiomyopathy caused by disruption of the fly's kidney-like ne-
phrocytes (Hartley et al., 2016). As Drosophila and mammalian SPARC
are both involved in collagen deposition, we asked whether a hypo-
morphic allele of Drosophila SPARC may alter the age-dependent de-
cline in cardiac function, age-dependent collagen deposition in the fly
heart or both.
The mutant SPARC allele is caused by a transgene insertion that
reduces the gene's expression by 60% in heterozygous flies (Hartley
et al., 2016). Both female and male SPARC heterozygous flies had ex-
tended lifespan compared to controls (Fig. 3). Maximum and median
lifespan for female SPARC heterozygotes were 72 days and 63 days,
nine and fifteen days longer than control's (Fig. 3B & C; P < 0.01).
Similarly, the maximum and median lifespan of male SPARC hetero-
zygous flies were 66 days and 52 days; nine and ten days longer than
controls (Fig. 3E & F; P < 0.01).
3.4. Impact of reduced SPARC expression on the age-dependent decline of
heart function
To establish if SPARC mediated the age-dependent decline of car-
diac function, heart function was monitored at one, three and six weeks
in control and SPARC heterozygous flies (Fig. 4). The cardiac function
of control flies (w1118) exhibited an age-dependent decline as expected,
whereas SPARC heterozygous flies showed no apparent change to
Fig. 2. Pericardin levels increase in the ageing heart.
(A) Confocal micrographs of z-projected stacks through the distal region of the hearts in flies of different ages stained with antisera to Pericardin. (B) The amount of Pericardin
fluorescence signal in 1 wk and 6 wk-old flies; n = 3; *P < 0.01. (C) Western blot of whole cell lysate of hearts from young (1 week) and older flies (6 weeks) stained with antibodies
raised to Pericardin. Actin was used as a loading control. (D) Quantification of polypeptide band intensity relative to the control (Actin). Data are the mean (± SEM) of measurements
from three independent experiments; *P < 0.05. (E–G) A single confocal slice through the distal region of the heart of young (1 week) and older flies (6 weeks); scale bars = 100 μm in
E; 10 μm in F. Boxes depict examples of regions used for quantifying Pericardin fibre thickness. (H) Pericardin fibre thickness in young (1 week) and older flies (6 weeks). Data are the
mean (± SEM) of fibres from at least 6 fibre measurements from four individual flies at each age. *P < 0.01.
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Fig. 3. Extended lifespan in SPARC heterozygous flies.
(A) Representative Kaplan-Meier plot of survival over time for flies of the control (w1118, black line) and SPARC heterozygous genotypes (red line). Data is from females for each
genotype. (B & C) Quantified data for maximum and median lifespan. Data represents mean of two independent trials using five groups of 15 flies of each genotype per trial. Data are
presented as the mean (± SEM) for each genotype. *P < 0.01.
Fig. 4. Extended cardiac health span in SPARC heterozygous flies.
(A) The adult beating heart was imaged in semi-intact preparations and functional parameters measured from videos captured at ~120 frames per second. The m-modes show heart
contractions over a 12 s period. M-modes from two different flies of each genotype, control (w1118) and mutant (SPARCMI00329 heterozygotes) are show for each age (1 and 6 weeks old).
Older wild type flies exhibit a disrupted heart rhythm, however this does not occur in SPARCMI00329 heterozygotes. (B) Quantified data for heart function showing that the age-dependent
decline in heart function recorded in the wild types (black lines) does not develop in SPARC+/− flies (red lines). Graphs show mean± SEM for each parameter. *P < 0.001, there is an
age-related change in the parameter; #P < 0.01 there is a difference between genotypes by 2-way-ANOVA, n = 20–50 flies per genotype, per time-point.
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cardiac function. Example m-modes (two-dimensional images of the
heart's contractions over time) show regular beating of the heart in
young (one week old control and SPARC heterozygous flies; Fig. 4A).
There was a significant change to the rhythmicity of cardiac contrac-
tions in six week old controls, characterised by a longer cardiac cycle
and periods of arrhythmia. This age-dependent change was not as ap-
parent in older SPARC heterozygous flies (lower m-modes in Fig. 4A),
which exhibited cardiac function comparable to that of younger flies.
Quantification of heart rate, heart period, diastolic and systolic inter-
vals as well as the arrhythmia index (a measure of beat-to-beat varia-
bility) confirmed there was an age-dependent change to all parameters
in controls but not SPARC heterozygous flies (Fig. 4B; P < 0.01 for
age-dependent decline in controls; whereas there was no significant
difference in SPARC heterozygous flies as they aged). In terms of car-
diac morphology and contraction distance (FS, fractional shortening),
there was a small but significant difference between the genotypes'
heart diameter at diastole (EDD) but not systole (ESD; Fig. 4B;
P < 0.01). However, neither genotype showed any age-related
changes to these three parameters (P < 0.05).
3.5. Over-expression of SPARC is sufficient to cause cardiomyopathy and
increase Pericardin deposition
To assess whether SPARC expression is sufficient to cause cardiac
dysfunction SPARC was over-expressed using Dorothy-Gal4 in peri-
cardial nephrocytes (large, kidney-like cells that lie adjacent to the
heart). Within one week of eclosion, cardiac function was severely
disrupted in flies over-expressing SPARC. Heart dysfunction mirrored
the phenotype of older flies, with the majority showing periods of ar-
rhythmia (71% of experimental flies versus 0% of controls; Fig. 5A and
B) and a very slow heart rate (Fig. 5C; P < 0.01). Pericardial ne-
phrocytes are also a major source of Pericardin, and over-expression of
SPARC in the nephrocytes caused a significant (~4-fold) increase to
Pericardin deposition around nephrocytes and the heart (Fig. 5D–F;
P < 0.01).
3.6. No evidence for reduced age-dependent collagen accumulation in
SPARC heterozygous flies
The impact of SPARCmodulation on heart function was followed up
by an analysis of collagen deposition in one and six-week-old control
and SPARC heterozygous flies. There was no apparent abnormality to
the fibrous Pericardin network in SPARC heterozygous flies compared
to controls, at either one or six weeks of age (Fig. 6A). Quantification of
fibre width in controls corroborated earlier findings, with older flies
having thicker fibres than younger flies (Fig. 6B); however the same
was true for SPARC heterozygous flies which also exhibited thicker
Pericardin fibres in older flies. Additionally, the Viking-GFP signal in
the heart valves of control and SPARC heterozygous flies was similar at
all ages (1, 2, 4 and 6 weeks; Fig. 6C; P > 0.05). Finally, Pericardin
was quantified in young and old flies by western blot and found to be
similar in young flies of each genotype and to increase comparably in
both genotypes (Fig. 6D–F).
4. Discussion
This study examined collagen deposition in the ageing Drosophila
heart. This was done using a well-known histological stain that detects
collagen (picrosirius red), a collagen-IV reporter fusion protein (Viking-
GFP) and immunological detection of the type-IV-like collagen,
Pericardin. The work tested the hypothesis that age-related changes to
either cardiac function or cardiac collagen accumulation may be
mediated by the matricellular protein, SPARC. There was evidence for
increased collagen deposition in the heart that accompanied cardiac
dysfunction. Age-dependent cardiac dysfunction was prevented in
SPARC heterozygous flies, however there was no evidence of reduced
collagen accumulation. SPARC over-expression was sufficient to cause
cardiomyopathy in young flies and this accompanied increased
Pericardin deposition. We conclude that the Drosophila heart develops a
fibrosis-like phenotype as it ages and that SPARC mediates cardiac
ageing and Pericardin accumulation. These findings suggest the ex-
istence of evolutionarily-conserved mechanisms of age-related collagen
deposition and that the Drosophila model may contribute to the study of
age-related fibrosis in humans. However, it remains unclear how
SPARC and the accumulation of collagen are linked to cardiac dys-
function in Drosophila.
Fibrosis can be regarded as an accumulation of extracellular matrix
(ECM) in a given tissue. In humans and mammalian models, fibrosis
typically develops as part of a tissue repair process, chronic in-
flammatory disease or ageing. Fibrotic outcomes in terms of organ
function appear to be determined not only by the gross accumulation of
ECM but also by the ratios of different ECM proteins (Karsdal et al.,
2017). The fact that we observed thickening of Pericardin fibres and an
accumulation of type-IV collagen is consistent with the development of
a fibrosis-like phenotype in the ageing Drosophila heart.
Accompanying the fibrosis-like phenotype was a decline of cardiac
function. Cardiac dysfunction in ageing was expected and reported
previously by others (Wessells et al., 2004; Kaushik et al., 2015). It is
known that collagen accumulates in the ageing mouse myocardium and
that this correlates with increased SPARC protein levels, as well as
cardiac stiffness (Bradshaw et al., 2010). These age-related changes to
collagen and cardiac stiffness are blunted in SPARC-null animals
(Bradshaw et al., 2010). Similarly, in mice heterozygous for SPARC,
collagen IV levels do not increase in ageing ventricles (de Castro Bras
et al., 2014). There is recent evidence that SPARC mediates the devel-
opment of cardiomyopathy in Drosophila (Hartley et al., 2016) and that
reduced expression of extracellular matrix (ECM) proteins can prevent
cardiac ageing in flies (Sessions et al., 2016). In accordance with these
findings it was hypothesised that reduced SPARC expression may pre-
vent the age-related decline of cardiac function in Drosophila, possibly
by modulating ECM deposition.
Using video microscopy of semi-intact heart preparations, it was
found that reduced SPARC expression prevented the age-dependent
decline of cardiac function. In addition, SPARC heterozygous flies had
extended median and maximal lifespan compared to controls. Hence,
reduced SPARC contributes to a longer life with an accompanying ex-
tension of cardiac health-span in Drosophila. In contrast, over-expres-
sion of SPARC in pericardial nephrocytes was sufficient to cause a se-
vere a cardiomyopathy in young flies that reflected the phenotype of
the aged heart. This cardiomyopathy accompanied the accumulation of
Pericardin, indicating that increased SPARC expression can promote
Pericardin deposition in Drosophila.
In contrast to the prediction that reduced SPARC may mediate the
accumulation of cardiac collagen in ageing flies and the over-expression
result, reduced SPARC expression was recorded as not having an impact
on the quantity of Viking or Pericardin deposited around the heart at
any age. Both control and SPARC heterozygous flies had similar levels
of cardiac Viking or Pericardin at one and six weeks of age, hence both
genotypes accumulated the collagens at a similar rate as they aged. This
suggests that SPARC's impact on cardiac health-span may depend on
mechanisms distinct to collagen accumulation. However, this conclu-
sion is offered tentatively because there is a wealth of data indicating
that SPARC mediates collagen assembly in other models (Camino et al.,
2008). Hence, it is not possible to conclude that gross accumulation of
collagen around the ageing heart was the reason for the decline in
cardiac function. One mechanism by which SPARC may affect cardiac
ageing is by activation of the Integrin-Linked Kinase pathway (ILK). It is
known that mammalian SPARC directly interacts with β-1 integrin and
activates ILK signalling (Weaver et al., 2008). A recent study in Dro-
sophila established that ILK regulates cardiac ageing (Nishimura et al.,
2014). It is therefore plausible that reduced SPARCmay prevent cardiac
ageing by reducing cardiac ILK signalling. However, this problem may
L. Vaughan et al. Experimental Gerontology 109 (2018) 59–66
64
be somewhat intractable because earlier work demonstrated that car-
diac-restricted knock-down of SPARC has deleterious effects on heart
development and function (Hartley et al., 2016). Additionally, the
glycation of collagen (the formation of cross-linkages between collagen
fibres) increases as organisms age and this affects basement membrane
flexibility (Paul and Bailey, 1996). Future work will examine whether
such qualitative changes to collagens occur in ageing Drosophila model
and whether they impact cardiac function.
In summary, the ageing Drosophila heart develops a fibrosis-like
phenotype typified by an accumulation of collagen-IV (Viking) and the
type-IV-like collagen, Pericardin. This is associated with age-dependent
decline in cardiac function. Whilst reduced SPARC can ameliorate the
decline of cardiac function it does so by a mechanism that appears in-
dependent of the gross changes to collagen accumulation measured in
this study. The findings imply that the Drosophila heart can be used to
model the genetic pathways contributing to age-dependent fibrosis in
higher organisms, including humans.
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.exger.2017.10.011.
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Fig. 5. Over-expression of SPARC causes cardiomyopathy and increased Pericardin deposition.
(A) M-modes showing the impact of SPARC over-expression on heart function at one week of age (from videos captured at 25 frames per second). (B) The percentage of hearts that were
arrhythmic in controls (‘C’, the UAS-SPARC parent line outcrossed to w1118) versus SPARC overexpression flies (driven by the Dorothy enhancer; ‘UAS-SPARC’); n = 7–10 flies for each
genotype. (C) Mean heart rate (± SEM) for the control and SPARC over-expression flies at one week. n = 7 flies for each genotype; *P < 0.01. (D) Confocal micrographs of adult 1 week
old hearts stained with wheat germ agglutinin (red, to highlight cell surfaces) and antibodies to Pericardin (cyan); scale bar = 100 μm. (E) Higher magnification of hearts stained with
WGA and Pericardin antibodies; scale bar = 50 μm. (F) Percentage coverage of heart staining positive for Pericardin (mean,± SEM); n = 5; *P < 0.01.
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Fig. 6. The levels of Viking and Pericardin in aged SPARC heterozygous hearts.
(A) Confocal slices through the distal region of the hearts of young (1 week) and older (6 week) control (w1118) and SPARC heterozygous flies (SPARCMI00329) stained with antibodies to
Pericardin. (B) Mean (± SEM) Pericardin fibre thickness in flies of different ages and genotype as described in the figure. ns = P > 0.05. n = 6 measurement from 4 four individual
flies. (C) Mean (± SEM) of the Viking-GFP signal at the valves of flies of different ages and genotype (w1118, black lines and SPARCMI00329, red lines). ns= P > 0.05. n = 6–10 flies of
each age and genotype. (D) Western blot of heart tissue stained with Pericardin antibodies and actin as a loading control. (E) Quantification of anti-Pericardin western blot band intensity
using at one week of age; ns= not statistically different from control. (F) Quantified data showing fold change in Pericardin band intensity; n = three blots; *P < 0.05 for there being a
difference in Pericardin at 6 weeks compared to 1 week.
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